4D pharma Statistics
Share Statistics
4D pharma has 0
shares outstanding. The number of shares has increased by 0.02%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | 0.02% |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.56 and the forward
PE ratio is null.
4D pharma's PEG ratio is
-0.02.
| PE Ratio | -0.56 |
| Forward PE | n/a |
| PS Ratio | 24.94 |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/FCF Ratio | -0.47 |
| PEG Ratio | -0.02 |
Financial Ratio HistoryEnterprise Valuation
4D pharma has an Enterprise Value (EV) of 9.74M.
| EV / Sales | 13.56 |
| EV / EBITDA | -0.32 |
| EV / EBIT | -0.26 |
| EV / FCF | -0.25 |
Financial Position
The company has a current ratio of 5.21,
with a Debt / Equity ratio of 0.39.
| Current Ratio | 5.21 |
| Quick Ratio | 5.16 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | -0.43 |
| Debt / FCF | -0.34 |
| Interest Coverage | -54.01 |
Financial Efficiency
Return on Equity is -98.53% and Return on Invested Capital is -69.34%.
| Return on Equity | -98.53% |
| Return on Assets | -54.32% |
| Return on Invested Capital | -69.34% |
| Revenue Per Employee | $6,773.58 |
| Profits Per Employee | $-301,301.89 |
| Employee Count | 106 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -22K |
| Effective Tax Rate | 0.07% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 3.27, so 4D pharma's
price volatility has been higher than the market average.
| Beta | 3.27 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.31 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 22.65 |
| Average Volume (20 Days) | 11,314 |
Income Statement
In the last 12 months, 4D pharma had revenue of 718K
and earned -31.94M
in profits. Earnings per share was -0.3.
| Revenue | 718K |
| Gross Profit | 718K |
| Operating Income | -31.38M |
| Net Income | -31.94M |
| EBITDA | -30.03M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.3 |
Full Income StatementBalance Sheet
The company has 20.97M in cash and 12.8M in
debt, giving a net cash position of 8.17M.
| Cash & Cash Equivalents | 20.97M |
| Total Debt | 12.8M |
| Net Cash | 8.17M |
| Retained Earnings | -180.17M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -37.92M
and capital expenditures -279K, giving a free cash flow of -38.2M.
| Operating Cash Flow | -37.92M |
| Capital Expenditures | -279K |
| Free Cash Flow | -38.2M |
| FCF Per Share | -0.36 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -4370.33% and -4448.19%.
| Gross Margin | 100% |
| Operating Margin | -4370.33% |
| Pretax Margin | -4451.25% |
| Profit Margin | -4448.19% |
| EBITDA Margin | -4181.89% |
| EBIT Margin | -4370.33% |
| FCF Margin | -5319.64% |
